Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_assertion type Assertion NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_head.
- NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_assertion description "[Using specific antibodies to mast cell tryptase, tissue macrophage, and bFGF, we demonstrate that cytoplasmic bFGF immunoreactivity is localized to 96.8 +/- 9.6% of tryptase-positive cells in human fibrotic lung tissue (n = 10), 82.3 +/- 6.9% of tryptase-positive cells in rheumatoid synovia (n = 6), and 93.1 +/- 4.8% of tryptase-positive cells in skin hemangioma (n = 5).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_provenance.
- NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_assertion evidence source_evidence_literature NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_provenance.
- NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_assertion SIO_000772 7545872 NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_provenance.
- NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_assertion wasDerivedFrom befree-2016 NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_provenance.
- NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_assertion wasGeneratedBy ECO_0000203 NP1312000.RAVs_5bTkz38IkDCgeOLe1HzmAFG4A_EZrhNOwX6dq32w130_provenance.